Novel Labs, Inc. – Trademark Portfolio
Entity Type: 03
Novel Labs, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 5 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include SHAREFILE. The owner is based in Raleigh, NC.
Suite 211
510 Glenwood Avenue
Raleigh, NC 27603
Showing of trademarks Trademarks
Trademark Classifications
Novel Labs, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Novel Labs, Inc. have?
Novel Labs, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 2 abandoned, 2 cancelled.
What trademark classes does Novel Labs, Inc. file in?
Novel Labs, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 38 (Telecommunications). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Novel Labs, Inc.'s most well-known trademarks?
Novel Labs, Inc.'s registered trademark portfolio includes well-known marks such as SHAREFILE. These are among 1 currently registered trademark in the portfolio.
What is Novel Labs, Inc.'s trademark registration success rate?
Novel Labs, Inc. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.